Evaluation of On-Couch CBCT Image Quality

NARecruitingINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

October 17, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

December 31, 2025

Conditions
Head and Neck CancerThoracic CancerAbdominal CancerPelvic Cancer
Interventions
DEVICE

HyperSight Imaging

Subjects receive both HyperSight imaging and conventional imaging, on their first day of radiation treatment, on their second day of treatment, and on their last day of treatment.

Trial Locations (1)

M5G 2M9

RECRUITING

Princess Margaret Cancer Centre (University Health Network), Toronto

All Listed Sponsors
lead

Varian, a Siemens Healthineers Company

INDUSTRY

NCT06576908 - Evaluation of On-Couch CBCT Image Quality | Biotech Hunter | Biotech Hunter